NASDAQ:ANGO

AngioDynamics, Inc Earning Date

USA |NASDAQ |USD

ANGO Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Jan 5, 2022 Nov 2021 $0.00 $-0.02 $0.01
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Jan 5, 2022 Nov 2021 $77.88M $76.97M $72.77M

Angiodynamics, Inc's next earnings date is Wednesday, Jan 5, 2022 for the fiscal quarter ending Nov 2021.

ANGO Earnings Date & History Chart

ANGO Earnings & Revenue Forecast

ANGO Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Nov 2021 4 $0.00 $-0.02 $0.01
Feb 2022 4 $-0.01 $-0.04 $0.02
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
May 2022 4 $0.00 $-0.07 $0.03
May 2023 4 $0.15 $0.11 $0.22

ANGO Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Nov 2021 0 / 2 $0.01 $0.01 $0.03
Feb 2022 1 / 1 $0.00 $0.01 $0.04
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
May 2022 2 / 1 $0.01 $0.01 $0.07
May 2023 0 / 0 $0.15 $0.15 $0.23

ANGO Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Nov 2021 4 $77.88M $77.13M $78.60M
Feb 2022 4 $77.34M $76.40M $78.16M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
May 2022 4 $313.70M $312.00M $314.70M
May 2023 4 $336.76M $330.04M $339.50M

ANGO Earnings Date & Revenue History

ANGO Earnings History

|
Show More
Show More

ANGO Revenue History

|
Show More
Show More

Angiodynamics, Inc Next Earnings Date & Report

ANGO Next Earnings Date & Report Preview: Nov 2021 (FQ)

ANGO's next earnings date is Wednesday, Jan 5, 2022 for the fiscal quarter ending Nov 30, 2021.

According to 4 analysts, the average EPS estimation for Angiodynamics, Inc's next quarterly earnings is $0.00, with a low EPS estimation of $-0.02, and a high estimation of $0.01.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 2 downward. The EPS 1 month trend is $0.01, the last 2 month trend is $0.01, and the 3 month trend is $0.03.

Based on 4 analysts, the average revenue estimation is $77.88M, with a low revenue estimation of $77.13M, and a high estimation of $78.60M.

Angiodynamics, Inc Previous Earnings Dates & Reports

ANGO Previous Earnings Date & Report Recap: Aug 2021 (FQ)

Angiodynamics, Inc's previous earnings date was Sep 30, 2021 for its fiscal quarter ended Aug 31, 2021.

ANGO's earnings per share (EPS) was $-0.02, beating the consensus analysts forecast of $-0.05 by 55.56%.

The EPS was higher than the previous fiscal quarter (May 2021) by -96.04%, and lower than the same period a year before (Aug 2020) by -200.00%.

Revenues were $76.97M, better than the forecast of $71.31M by 7.94%, up by 0.17% from the previous quarter , and up by 9.62% from the same period last year.

The company reported a net income of $-6.97M.

Free cash flow for the quarter was $-9.93M , compared to $11.58M last quarter and $-7.25M a year before.

ANGO ended the quarter with $25.00M in total debt, an increase of 25.00% compared to the previous quarter, and a decrease of -37.50% compared to the same quarter a year before.

ANGO Previous Earnings Date & Report Recap: May 2021 (FY)

Angiodynamics, Inc's previous annual earnings date was Jul 13, 2021 for its fiscal year ended May 31, 2021.

ANGO's earnings per share (EPS) was $-0.46, missing the consensus analysts forecast of $0.05 by -1010.60% , and lower than the previous year's EPS (May 2020) by -605.89%.

Revenues were $291.01M, better than the forecast of $286.86M by 1.45%, and up by 10.17% from previous year's revenue.

The company reported a net income of $-31.55M.

Angiodynamics, Inc reported a free cash flow of $18.91M for its fiscal year, compared to $-22.14M a year ago.

The company ended the fiscal year with $20.00M in total debt, a decrease of -50.00% compared to the previous year.